Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors User montaukwhaler, in the non small cell lung cancer subreddit, 15 Oct 2016